SelectScience
Join Free
Accelerating Science
NewsLife Sciences

Olink Explore Cancer Biomarker Discovery Challenge

Olink Proteomics

Olink is sponsoring a Cancer Biomarker Discovery Challenge for Innovative Researchers in Europe

15 Jun 2023
Dora Wells
Clinical Content Editor

Industry news

Olink is pleased to announce the Olink® Explore Cancer Biomarker Discovery Challenge. This award covers the Olink Explore 3072 application and is valid only for researchers based in Europe. The Olink Cancer Biomarker Discovery Challenge is an exciting opportunity for early-stage career cancer researchers seeking to identify new biomarkers for the detection, characterization, and treatment of cancer.

Olink offers high quality protein biomarker discovery based on a flexible and scalable technology platform. Olink has taken proteomics to the next level by enabling high throughput, large scale analysis of thousands of proteins simultaneously, while using less than a drop of blood and maintaining exceptional levels of specificity, sensitivity, and dynamic range

Olink is inviting researchers to submit an abstract sharing their plans to use Olink Explore 3072 in their research. The goal of this program is to enable researchers in Europe to generate pilot data to submit in support of future grant applications, and to promote the use of cutting-edge solutions using Olink Explore 3072 for proteomics research.

Join the competition today>>

Links

Olink ProteomicsCompany website

Tags

BiomarkersBiomarkers are biological markers which can be measured and evaluated to indicate a biological state. The use of biomarkers in research and diagnosis can indicate a normal or disease state or drug response of cells / tissues. Biomarkers include genetic markers, cell surface markers such as antigens, antibodies or receptors and secreted molecules such as cytokines. An assay system is required for identification of biomarkers. :ProteomicsProteomics is the systemic bioinformatics study of proteins and amino acids, including their structure, size, function and identification. Tools used in proteomics include chromatography, blotting and gels, protein arrays, mass spectrometry and ELISA and associated analysis software. Analyzers and proteomic systems should be sensitive, high resolution, fast and may be automated for high-throughput.Cancer ResearchCancer research aims to understand the mechanisms of cancer development and progression to improve prevention, diagnosis, and treatment. From molecular biology to clinical trials, research spans a wide range of disciplines, including immunotherapy, targeted therapies, and drug discovery. Explore the best cancer research products in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.Biomarker DiscoveryClinical biomarkers refer to substances related to known medical conditions that can be accurately measured <i>in vitro</i>. Biomarkers can be used to diagnose presence of a disease and indicate disease severity. The discovery of new biomarkers is incredibly valuable in the field of diagnostics.

Related articles

Olink Explore Cancer Biomarker Discovery Challenge